Blood-based proteomic biomarkers of Alzheimer’s disease pathology
The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges for early diagnosis and yet allows for the possibility of the development of disease modifying treatments for secondary prevention. It is, therefore, of importance to develop biomarkers, in particular, in the pr...
Main Authors: | Baird, A, Westwood, S, Lovestone, S |
---|---|
Format: | Journal article |
Udgivet: |
Frontiers
2015
|
Lignende værker
-
The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
af: Westwood, S, et al.
Udgivet: (2017) -
A decade of blood biomarkers for Alzheimer's disease research: an evolving field, improving study designs, and the challenge of replication
af: Shi, L, et al.
Udgivet: (2018) -
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
af: Delvenne, A, et al.
Udgivet: (2024) -
Complement biomarkers as predictors of disease progression in Alzheimer's disease.
af: Hakobyan, S, et al.
Udgivet: (2016) -
Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly
af: Westwood, S, et al.
Udgivet: (2016)